QuantuMDx receives CTDA approval for sale of Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay

Read More

QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform

Read More

QuantuMDx Enters into Cooperation Agreement with Sansure Biotech

Read More

QuantuMDx announces forthcoming webinar: Rising to the challenge: diagnosing, treating and managing respiratory infections using rapid PCR testing at the Point of Need

Read More

QuantuMDx’s Q-POC™ Platform Shortlisted for SelectScience Clinical Scientists’ Choice Awards

Read More

Elaine Warburton OBE Wins InspiringFifty Europe 2022 Award

Read More

QuantuMDx wins Special Recognition Award at the 2022 Med-Tech Innovation Awards

Read More

QuantuMDx launches New PCR Respiratory Panel 

Read More

QuantuMDx wins MediLink Award 2022

Read More

New Website Launch

Read More

QuantuMDx wins two Bionow Awards 2021

Read More

QuantuMDx Wins Made in North East Medical Life Sciences Award 2022

Read More

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

Read More

Martin Walton appointed as Chief Financial Officer

Read More

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

Read More

QuantuMDx confirm its diagnostic tests remain able to detect all known variants of COVID-19 including the new variant from South Africa, B.1.1.529

Read More

QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech

Read More

QuantuMDx partners with Cignpost Diagnostics

Read More

QuantuMDx launches Q-POC™ – a PCR diagnostic system

Read More

QuantuMDx included on PHE Microbiology Framework

Read More

Mirre de Noo appointed as non-executive director

Read More

QuantuMDx completes £11m funding round

Read More

Prime Minister, Boris Johnson visits QuantuMDx

Read More